Skip to main content
. 2022 Mar 19;10(3):715. doi: 10.3390/biomedicines10030715

Table 1.

Research articles analyzed and their main results.

Author Year Type of Study Objective Outcome
Ronan Le Goffic et al. [11] 2011 Research study Evaluation of IL-33 expression and release in lungs of influenza A virus-infected mice in vivo and in murine respiratory epithelial cells Significant increase in mRNA expression of IL-33 in the virus-infected mice at day 3, compared with non-infected control mice. A significant correlation was found between IL-33 mRNA induction and mRNA levels of TNF-a, IFN-g, and IL-6, but not with IL-1b. The protein expression of IL-33 in virus-infected lungs and in BAL was significantly higher than in controls, especially at day 3. We found a significant increase in IL-33 mRNA expression in IAV-infected transformed murine respiratory epithelial cell line, MLE-15, and human pulmonary epithelial cell line A549, compared with non-infected cells.
Jia-Rong Bian et al. [12] 2014 Research study Evaluation of serum levels of pro-inflammatory cytokines in adult patients with seasonal influenza infection Higher serum concentration of IL-6, IL-33, and TNF-α at admission, compared to controls. Higher levels of IL-33 were found in influenza A-infected patients.
Kayamuro H et al. [13] 2010 Research study Evaluation of specific antibody response and specific cellular toxicity in intranasally immunized mice with hemagglutinin and various cytokines IL-1 family cytokines were able to induce the highest IgG and IgA production. IL-33 and IL-18 were able to elicit both Th1- and Th2-type cytokine responses and high-avidity CD8+ cytotoxic lymphocytes.
Xi-zhi J. Guo et al. [14] 2018 Research study Evaluation of γδ T cells and production of IL-33 in mouse models of influenza infection IL-33 induces a local type-2 immune response with increased accumulation of type-2 innate lymphoid cells and T regulatory cells in the lung, which promotes tissue repair and lung integrity after influenza infection.
Monticelli et al. [15] 2011 Research study Evaluation of the role of innate lymphoid cells after influenza virus infection Innate lymphoid cells, induced by IL-33, are of crucial importance in promoting airway epithelial integrity and lung tissue homeostasis through production of the epidermal growth factor family member amphiregulin.
Robinson et al. [16] 2018 Research study Evaluation of the role of IL-33 in mucosal anti-bacterial host defense in influenza infection and bacterial superinfection Reduction in IL-33 correlates with a negative outcome after influenza infection and bacterial superinfection. Its restoration is correlated with an improvement in bacterial clearance, not related to innate lymphoid cells or type-2 macrophages but to neutrophil recruitment.
Chae Won Kim et al. [17] 2019 Research study Evaluation of antiviral protection against influenza virus infection by exogenous IL-33 Exogenous administration of IL-33 was related to a better outcome in mice infected with influenza IL-33 virus. IL-33 increased the number of innate lymphoid cells, eosinophils, and dendritic cells and CD8+ T-cell activity.
García-García ML, Calvo C et al. [18]. 2017 Experimental study Investigate whether infants exhibit enhanced nasal airway secretion of TSLP, IL-33, and periostin during natural respiratory viral bronchiolitis Bronchiolitis caused by common respiratory viruses is associated with elevated nasal levels of TSLP, IL-33, and periostin, factors known to be important in the development of Th2-response.
Mehta AK, Duan W et al. [19] 2016 Experimental study Examine whether rhinovirus infection of the respiratory tract can block airway tolerance by modulating Treg cells Infection of the respiratory epithelium with rhinovirus can antagonize tolerance to inhaled antigen through combined induction of TSLP, IL-33, and OX40 ligand, and this can lead to susceptibility to asthmatic lung inflammation.
Jarjour NN, Esnault S [20] 2014 Review Demonstrate the mechanism of exacerbation in human asthma during rhinovirus infection IL-33 is likely a major cause of viral-induced asthma exacerbations and a potential therapeutic target in asthma.
Jackson DJ, Makrinioti H et al. [21] 2014 Experimental study Assess whether rhinovirus induces a type-2 inflammatory response in asthma in vivo and define a role for IL-33 in this pathway IL-33 and type-2 cytokines are induced during a rhinovirus-induced asthma exacerbation in vivo.
Han M, Rajput C et al. [22] 2017 Experimental study IL-33 and TSLP expression is also induced by RV infection in immature mice and required for maximum ILC2 expansion and mucous metaplasia The generation of mucous metaplasia in immature, RV-infected mice involves a complex interplay between the innate cytokines IL-25, IL-33, and TSLP.
Jurak LM, Xi Y et al. [23] 2018 Case-control study Investigate the effects of IL-33 on rhinovirus (RV)-induced immune responses by circulating leukocytes from people with allergic asthma, and how this response may differ from non-allergic controls RV infections and IL-33 might interact in asthmatic individuals to exacerbate type-2 immune responses and allergic airway inflammation.
Calvén J, Akbarshahi H et al. [24] 2015 Experimental study Investigate effects of epithelial-derived media and viral stimuli on IL-33 expression in human BSMCs RV infection of BSMCs and activation of TLR3 and RIG-I-like receptors cause expression and production of IL-33.
Ramu S, Calvén J et al. [25] 2020 Case-control study Compare levels of RV-induced IL-33 in BSMCs from healthy and asthmatic subjects RV infection cause higher levels of IL-33 and increased pro-inflammatory and type-2 cytokine release in BSMCs from patients with non-severe asthma.
Ganesan S, Pham D et al. [26] 2016 Experimental study Examine the role of TLR2 and IRAK-1 in RV-induced IFN-β, IFN-λ1, and CXCL-10, which require signaling by viral RNA RV stimulates CXCL-10 expression via the IL-33/ST2 signaling axis, and TLR2 signaling limits RV-induced CXCL-10 via IRAK-1 depletion at least in airway epithelial cells.
Gimenes JA Jr, Srivastava V et al. [27] 2019 Experimental study Examine the mechanisms underlying the RV-induced persistent inflammation and progression of emphysema in mice with COPD phenotype RV may stimulate expression of CXCL-10 and IFN-γ via activation of the ST2/IL-33 signaling axis, which in turn promotes accumulation of CD11b+/CD11c+ macrophages and CD8+ T cells.
Gajewski A, Gawrysiak M et al. [28] 2019 Experimental study Analyze the effect of IL-33, the cytokine widely distributed in large amounts in airways of asthmatic individuals, on the HRV-induced inflammatory response in the human lung vascular endothelium. In asthmatics, IL-33 may facilitate higher viral load in the lung vascular endothelium, while IL-33-orchestrated cytokine milieu may enhance innate inflammatory responses without any concomitant increase in antiviral innate and adaptive mechanisms.
Werder RB, Zhang V et al. [29]. 2018 Experimental study Determine whether anti-IL-33 therapy is effective during disease progression, established disease, or viral exacerbation using a preclinical model of chronic asthma and in vitro human primary airway epithelial cells (AECs) The latter phenotype was replicated in rhinovirus-infected human AECs, suggesting that anti-IL-33 therapy has the additional benefit of enhancing host defense
Han Xu et al. [30] 2017 Research Study Evaluation of the role of natural helper cells in influenza virus-induced airway hyper-responsiveness Blockage of IL-33 reduces natural helper cell recruitment in lungs, thus suggesting IL-33 is necessary for activating Th2-type response.
Wu Yi-Hsiu et al. [7] 2019 Research study Evaluation of the individual roles of IL-33-activated innate immune cells, including ILC2s and ST2+ myeloid cells, in RSV infection-triggered pathophysiology. IL-33 is crucial for the activation of ILC2s and the development of airway hyperreactivity and airway inflammation. IL-33 through lung myeloid cells mediates cellular infiltration but not airway hyperreactivity.
Liwen Zhang et al. [31] 2021 Research study Investigation of the role of NF-κB/IL-33/ST2 axis on RSV-induced acute bronchiolitis IL-33 level was significantly elevated in infants with RSV acute bronchiolitis. The NF-κB/IL-33/ST2 axis is important in the establishment of the Th2 environment after RSV infection. The use of an anti-IL-33 antibody blocks that mechanism, thus suggesting the crucial role of IL-33, especially produced by macrophages.
Allison E. Norlander and R. Stokes Peebles, Jr. [32] 2020 Review Review of the impact of L-33, IL-25, thymic stromal lymphopoietin (TSLP), and high mobility group box 1 after RSV infection ILC2 activation leads to the production of type-2 cytokines and the induction of a type-2 response during RSV infection.
Carolina Augusta Arantes Portugal et al. [6] 2020 Research study Assess the role of IL-33-ST2 axis in acute lower respiratory infection by RSV IL-33 and ST2 in nasopharyngeal aspirates on admission were associated with higher risk for mechanical ventilation.
Jing Liu et al. [33] 2015 Research study Evaluation of IL-13-IL-33-ST2 axis and natural helper cells in the development of RSV-induced airway inflammation RSV infection induces an increase in the number of IL-13-producing natural helper cells in an IL-33-dependent pathway.
Jordy Saravia et al. [34] 2015 Research Study Evaluation of the pathogenic mechanisms responsible for RSV-induced immunopathophysiology Infection with RSV induced rapid IL-33 expression and an increase in ILC2 numbers in the lungs of neonatal mice, in contrast with adult mice. Blocking IL-33 during infection was sufficient to inhibit RSV airway hyperresponsiveness, Th2 inflammation, eosinophilia, and mucus hyperproduction, whereas administration of IL-33 to adult mice during RSV infection was sufficient to induce RSV disease. Elevated IL-33 and IL-13 were observed in nasal aspirates from infants hospitalized with RSV.
Feifei Qi et al. [35] 2015 Research study Evaluation of cellular source of IL-33, particularly the types of IL-33-producing cells in innate immune cells during RSV infection IL-33 plays a key role in RSV-induced airway inflammation. Alveolar macrophages and dendritic cells are a cellular source of IL-33. RSV infection increases expression of IL-33 in pulmonary dendritic cells but not in interstitial macrophages. Macrophages and dendritic cells mediate the production of IL-33 through interaction with TLR3 or TLR7.
Feifei Qi et al. [36] 2017 Research study Evaluation of specific signaling pathways for activation of macrophages during RSV infection RSV infection can promote both the expression of mRNAs for MAPK molecules and the levels of MAPK proteins in lung macrophages. This mechanism may participate in the process of RSV-induced IL-33 secretion by macrophages, demonstrated by an attenuation of IL-33 production when mice were treated with a special MAPK inhibitor before RSV infection.
Stier MT et al. [37] 2016 Research study Determination of the capacity of RSV infection to stimulate group 2 innate lymphoid cells (ILC2s) and the associated mechanism in a murine model RSV-infected IL-33 knock-out mice presented a reduced lung concentration of IL-13, thus highlighting an important role for IL-33 in ILC2 activation.
Zeng S. et al. [38] 2015 Research study Evaluation and understanding of the function of IL-33/ST2 signaling pathway during respiratory syncytial virus (RSV) infection Following intranasal infection with RSV, BALB/c mice showed a marked increase in the production of IL-33, with elevated expression of ST2 mRNA as well as a massive infiltration of CD45+ST2+ cells in the lungs, suggesting that during the early phase of RSV infection, IL-33 target cells, which express ST2 on cell surface, may play a critical role for the development of RSV-induced airway inflammation. Indeed, blocking ST2 signaling using anti-ST2 monoclonal antibody diminished not only RSV-induced eosinophil recruitment, but also the amounts of Th2-associated cytokines, particularly IL-13, and Th17-type cytokine IL-17A in the lungs of infected mice.
Bertrand P. et al. [39] 2015 Research study Evaluation of possible mechanisms that connect RSV bronchiolitis to asthma and recurrent wheezing Patients with family history of atopy presented a high level of IL-33 in nasopharyngeal aspirates.
García-García ML et al. [18] 2017 Research study Assessment of the role of thymic stromal lymphopoietin, IL-33, and periostin in viral bronchiolitis Infants with bronchiolitis had higher levels of TSLP (p = 0.02), IL-33 (p < 0.001) and periostin (p = 0.003) than healthy controls. TSLP and IL-33 were more common in coinfections, mainly RSV and rhinovirus, than in single-infections (p < 0.05).
Vu et al. [40] 2019 Research study Investigate the role of mucosal innate immune responses to RSV and respiratory viral load in infants hospitalized with the natural disease Levels of IL-4, IL-13, IL-33, and IL-1β were significantly higher in nasal aspirates of patients with severe disease compared with those of patients with moderate disease. The authors highlighted the prevalence of type-2 responses to RSV infection in infants and suggested an important role of ILC2 in shaping the immune response early during RSV infection.
Stav-Noraas TE et al. [41] 2017 Experimental study Investigate whether endothelial IL-33 expression is augmented by adenoviral activation of the DNA damage machinery Adenoviral transduction stimulates IL-33 expression in endothelial cells in a way that depends on the DNA-binding protein MRE11 and the antiviral factor IRF1 but not on downstream DNA damage response signaling
Zhang Y et al. [42] 2018 Experimental study Evaluate the protective effects of Ad5-gsgAM in an ovalbumin (OVA)-induced asthmatic mouse model Modulating the IL-33/ST2 axis via adenovirus-vectored mycobacterial antigen vaccination may provide clinical benefits in allergic inflammatory airways disease
Yin H et al. [43] 2012 Experimental study Determine whether high levels of local soluble ST2 can ameliorate ovalbumin (OVA)-induced allergic airway inflammation Single intranasal delivery of Ad-sST2-Fc to OVA-sensitized mice reduces significantly the production of Th2 cytokines, bronchoalveolar lavage eosinophil infiltrates and histopathological changes in the lung. Moreover, the protective effect is related to blocking IL-33/ST2L signaling.
Stanczak M.A. [44] 2021 Observational study To analyze the seroprevalence and immune responses in subjects exposed to SARS-CoV-2
  • SARS-CoV-2 peptide stimulation elicits IL-33 expression in seropositive individuals.

  • After recovery from COVID-19, individuals have persisting, circulating PBMCs that produce IL-33 in response to virus-specific T cell activation, which correlates with seropositivity.

Liang Y. [10] 2021 Original article, in vitro study To test whether SARS- CoV-2 infection induces IL-33 expression in epithelial cells IL-33 transcript levels significantly increased in cell lines at 72 h post-infection.
Burke H. [45] 2020 Observational study To measure serum IL-6, IL-8, TNF, IL-1β, GM-CSF, IL-10, IL-33 and IFN-γ using a multiplex cytokine assay, in 100 hospitalized patients with COVID-19 Increased IL-33 levels were associated with adverse outcomes.
Munitz A. [46] 2021 Original article To investigate a correlation of IL-33 and IgG seroconversion with disease severity
  • Notable elevation in the levels of IL-33 was found in moderate/severe patients in comparison with mild patients.

  • Anti RBD IgG was higher in the moderate/severe cohort, clustered together with IL-33.

Gaurav R. [47] 2021 Observational-post mortem To characterize IL-33 expression in the lungs of patients with fulminant COVID-19, compared with other inflammatory lung diseases
  • Patients with COVID-19 had low IL-33 expression compared with control subjects.

  • In post-COVID fibrosis, IL-33 was increased compared to levels in COPD and IPF.

Jeican I. [48] 2021 Original article To perform a comparative morphological characterization of the respiratory nasal mucosa in CRSwNP versus COVID-19 and tissue IL-33 The tissue IL-33 concentration in CRSwNP was higher than in COVID-19.
Markovic S. [49] 2021 Observational study To analyze the correlation of IL-33 and other innate immunity cytokines with disease severity
  • In a more progressive stage of COVID-19, increased IL-33 facilitates lung inflammation.

  • IL-33 correlates with clinical parameters of COVID-19.

Zeng Z. [9] 2020 Original article To study the role of soluble ST2 in COVID-19 and its relationship with inflammatory status and disease severity
  • Serum sST2 levels were significantly increased in COVID-19 patients and were positively correlated with CRP but negatively correlated with CD4+ and CD8+ T lymphocyte counts.

  • Serum sST2 levels in non-surviving severe cases were persistently high during disease progression.